Skip to search formSkip to main contentSkip to account menu

Haemophilus B Conjugate Vaccine

Known as: Haemophilus influenzae b vaccine, Haemophilus influenzae B Polysaccharide Conjugate Vaccine (PRP-OMP), Haemophilus b oligosaccharide conjugate vacccine 
A vaccine against serotype b of the Gram-negative bacterium H. influenzae (Hib). Hib vaccines contain polysaccharide-protein conjugate antigens that… 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (3)

DTaP-Haemophilus influenzae type b conjugate vaccineHibTITER protein, Haemophilus influenzaePedvaxHIB
Vaccines, Conjugate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
This report presents new recommendations adopted in June 2009 by CDC's Advisory Committee on Immunization Practices (ACIP… 
2003
2003
Impact of the introduction of a combined Haemophilus B conjugate vaccine and hepatitis B recombinant vaccine on vaccine coverage rates in a large west coast health maintenance organization
We evaluated the effect of introduction of a combined hepatitis B-Haemophilus influenzae b vaccine on vaccine coverage rates in a… 
1998
1998
Interleukin-6, C-Reactive Protein, and Abnormal Cardiorespiratory Responses to Immunization in Premature Infants
Objective. We report our experience with routine immunization of 89 premature infants in the neonatal intensive care unit because… 
Highly Cited
1998
Highly Cited
1998
Safety and immunogenicity of a combined five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus B conjugate vaccine administered to infants at two, four and six months of…
1996
1996
FDA approval of a Haemophilus b Conjugate Vaccine combined by reconstitution with an acellular pertussis vaccine.
  • MMWR. Morbidity and mortality weekly report
  • 1996
  • Corpus ID: 30448641
On September 27, 1996, the Food and Drug Administration (FDA) licensed a Haemophilus b Conjugate Vaccine (ActHIB) combined by… 
Highly Cited
1994
Highly Cited
1994
Safety and immunogenicity in young infants of Haemophilus b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis-enhanced inactivated poliovirus vaccine.
Because inactivated poliovirus vaccine (IPV) and Haemophilus influenzae b vaccine are advised in many programs and may be… 
1993
1993
Recommendations for use of Haemophilus b conjugate vaccines and a combined diphtheria, tetanus, pertussis, and Haemophilus b vaccine. Recommendations of the advisory Committee on Immunization…
These recommendations include information on two vaccines recently licensed for use among infants: Haemophilus b Conjugate… 
1991
1991
Haemophilus b conjugate vaccines for prevention of Haemophilus influenzae type b disease among infants and children two months of age and older. Recommendations of the immunization practices advisory…
  • MMWR Recommendations and Reports
  • 1991
  • Corpus ID: 46326942
These recommendations include information on use of two vaccines recently licensed for use with infants: Haemophilus b Conjugate… 
1991
1991
Haemophilus b disease after vaccination with Haemophilus b polysaccharide or conjugate vaccine.
The reported frequency of invasive Haemophilus influenzae type b disease occurring within 1 year after immunization was compared… 
1990
1990
Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease
Children younger than 2 years of age with previous invasive Haemophilus influenzae (Hib) type b disease may not develop… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)